Twit­ter dis­ar­ray con­tin­ues as phar­ma ad­ver­tis­ers ex­tend paus­es and look around for op­tions, but keep tweet­ing

Phar­ma ad­ver­tis­ers on Twit­ter are done — at least for now. Ad spend­ing among the pre­vi­ous top spenders flat­tened even fur­ther last week, ac­cord­ing to the lat­est da­ta from ad track­er Path­mat­ics, amid on­go­ing tur­moil af­ter bil­lion­aire boss Elon Musk’s takeover now one month ago.

Among 18 top ad­ver­tis­ers tracked for End­points News, on­ly two are spend­ing: GSK and Bay­er. GSK spend­ing for the full week through Sun­day was min­i­mal at just un­der $1,900. Mean­while, Ger­man drug­mak­er Bay­er re­mains the in­dus­try out­lier up­ping its spend­ing to $499,000 last week from $480,000 the pre­vi­ous week. Bay­er’s spend­ing al­so marks a big in­crease from a month ago and be­fore the Musk takeover, when it spent $16,000 per week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER